|

MT-125 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Myosin Therapeutics Inc.1

Indications

  • Glioblastoma (GBM)1
  • Cancer1

Phoenix, Arizona1 trial

A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients

Mayo Clinic Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.